Cannabis companies Columbia Care Inc. and Canopy Growth Corporation have both entered into subscription agreements with institutional investors for private placements, raising a total of $75 million. The funds will be used to strengthen financial positions, reduce debts, and support general corporate purposes, indicating returning investor interest in the cannabis sector.
New York Community Bancorp's Flagstar Bank is set to lay off around 1,900 employees as part of a strategic transformation plan, including the sale of its mortgage servicing unit to Mr. Cooper.
Donald Trump claims Apple CEO Tim Cook called him to discuss concerns over EU-imposed fines on Apple, totaling $17 billion. The conversation highlights ongoing tensions between U.S. tech giants and European regulators.
Google is integrating its Gemini app team with DeepMind to streamline AI development and improve feedback loops, as part of a broader reorganization to enhance its AI capabilities.
Travelers Companies Inc. reported a significant increase in third-quarter profits, driven by strong underwriting gains and investment income, despite facing record catastrophe losses. This led to a surge in the company's stock price.
The US FDA has expanded the approval of Avadel Pharmaceuticals' sleep disorder drug Lumryz for use in children aged 7 and older, enhancing its market potential and competition with Jazz Pharmaceuticals.
Netflix's stock price rose significantly after the company reported better-than-expected third-quarter earnings, driven by strong subscriber growth and increased ad-tier memberships.
Wipro, India's fourth-largest software company, surpasses Q2 revenue estimates due to increased U.S. client spending, despite a slight revenue decline.
Litmus Music, supported by Carlyle Group, has acquired the rights to Randy Newman's song catalog, including his work for Disney's 'Toy Story' films.
Expedia's stock surged following reports that Uber has considered a takeover, aiming to expand its services into travel booking.
Rentokil Initial's 2025 profits are expected to be affected by delays in realizing benefits from its acquisition of Terminix, compounded by weak North American sales.